Rep/Cap Gene Amplification and High-Yield Production of AAV in an A549 Cell Line Expressing Rep/Cap
Open Access
- 1 May 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 5 (5), 644-649
- https://doi.org/10.1006/mthe.2001.0591
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Characterization of Adenovirus-Induced Inverted Terminal Repeat-Independent Amplification of Integrated Adeno-Associated Virus rep-cap SequencesJournal of Virology, 2001
- Selective Rep-Cap Gene Amplification as a Mechanism for High-Titer Recombinant AAV Production from Stable Cell LinesMolecular Therapy, 2000
- Production of recombinant adeno-associated virusPublished by Elsevier ,2000
- Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirusGene Therapy, 1999
- High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle VirusHuman Gene Therapy, 1998
- Factors Influencing Recombinant Adeno-Associated Virus ProductionHuman Gene Therapy, 1998
- Interaction of human papillomavirus type 16 and adeno-associated virus type 2 co-infecting human cervical epithelium.Journal of General Virology, 1997
- A Novel Adenovirus—Adeno-Associated Virus Hybrid Vector That Displays Efficient Rescue and Delivery of the AAV GenomeHuman Gene Therapy, 1996
- A New Strategy for Large-Scale Preparation of High-Titer Recombinant Adeno-Associated Virus Vectors by Using Packaging Cell Lines and Sulfonated Cellulose Column ChromatographyHuman Gene Therapy, 1996
- Cell Lines for the Production of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1995